These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29958693)

  • 1. Intradermal active full-length DNA Aβ42 immunization via electroporation leads to high anti-Aβ antibody levels in wild-type mice.
    Rosenberg RN; Fu M; Lambracht-Washington D
    J Neuroimmunol; 2018 Sep; 322():15-25. PubMed ID: 29958693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a DNA Aβ42 Vaccine in Aged NZW Rabbits: Antibody Kinetics and Immune Profile after Intradermal Immunization with Full-Length DNA Aβ42 Trimer.
    Lambracht-Washington D; Fu M; Wight-Carter M; Riegel M; Rosenberg RN
    J Alzheimers Dis; 2017; 57(1):97-112. PubMed ID: 28222511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer.
    Lambracht-Washington D; Fu M; Frost P; Rosenberg RN
    Alzheimers Res Ther; 2017 Apr; 9(1):30. PubMed ID: 28441965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.
    Qu B; Rosenberg RN; Li L; Boyer PJ; Johnston SA
    Arch Neurol; 2004 Dec; 61(12):1859-64. PubMed ID: 15596606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.
    Lambracht-Washington D; Qu BX; Fu M; Eagar TN; Stüve O; Rosenberg RN
    JAMA; 2009 Oct; 302(16):1796-802. PubMed ID: 19861672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of a DNA vaccine for Alzheimer's disease by electroporation versus gene gun generates potent and similar immune responses.
    Davtyan H; Ghochikyan A; Movsesyan N; Ellefsen B; Petrushina I; Cribbs DH; Hannaman D; Evans CF; Agadjanyan MG
    Neurodegener Dis; 2012; 10(1-4):261-4. PubMed ID: 22301697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
    Maier M; Seabrook TJ; Lazo ND; Jiang L; Das P; Janus C; Lemere CA
    J Neurosci; 2006 May; 26(18):4717-28. PubMed ID: 16672644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
    Kim HD; Jin JJ; Maxwell JA; Fukuchi K
    Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation.
    Xing X; Sha S; Li Y; Zong L; Jiang T; Cao Y
    J Neurol Sci; 2012 Feb; 313(1-2):17-21. PubMed ID: 22029939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice.
    Qu B; Boyer PJ; Johnston SA; Hynan LS; Rosenberg RN
    J Neurol Sci; 2006 May; 244(1-2):151-8. PubMed ID: 16556449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice.
    Liu B; Frost JL; Sun J; Fu H; Grimes S; Blackburn P; Lemere CA
    J Neurosci; 2013 Apr; 33(16):7027-37. PubMed ID: 23595760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
    Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
    Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice.
    Petrushina I; Ghochikyan A; Mkrtichyan M; Mamikonyan G; Movsesyan N; Ajdari R; Vasilevko V; Karapetyan A; Lees A; Agadjanyan MG; Cribbs DH
    J Neuroinflammation; 2008 Sep; 5():42. PubMed ID: 18823564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the brain transcriptome after DNA Aβ42 trimer immunization in a 3xTg-AD mouse model.
    Lambracht-Washington D; Fu M; Hynan LS; Rosenberg RN
    Neurobiol Dis; 2021 Jan; 148():105221. PubMed ID: 33316368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
    Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
    J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.
    Qu BX; Lambracht-Washington D; Fu M; Eagar TN; Stüve O; Rosenberg RN
    Vaccine; 2010 Jul; 28(32):5280-7. PubMed ID: 20562015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice.
    Qu BX; Xiang Q; Li L; Johnston SA; Hynan LS; Rosenberg RN
    J Neurol Sci; 2007 Sep; 260(1-2):204-13. PubMed ID: 17574274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease.
    Lambracht-Washington D; Qu BX; Fu M; Anderson LD; Eagar TN; Stüve O; Rosenberg RN
    J Neuroimmunol; 2013 Jan; 254(1-2):63-8. PubMed ID: 23036592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.